Reiji Yokoyama

Title: The Innovative Journey of Reiji Yokoyama

Introduction: Reiji Yokoyama, a notable inventor based in Hyogo, Japan, has made significant contributions to the field of pharmaceutical formulations. With one patent to his name, he exemplifies the creative spirit and technical expertise that drive innovation in the industry.

Latest Patents: Yokoyama's most recent patent is titled "Solid dosage form containing quinazoline derivative." This patent presents a formulation comprising the compound represented by formula (I) or its pharmaceutically acceptable salts, along with light-stabilizing substances and polymers. Specifically, the invention utilizes titanium oxide and talc as light-stabilizing substances, coupled with hypromellose as the polymer. The innovative formulation is designed to minimize the increase of related substances and demonstrate minimal color changes under light irradiation, showcasing Yokoyama's commitment to advancing pharmaceutical technology.

Career Highlights: Reiji Yokoyama is currently employed by Shionogi & Company Limited, a leader in the pharmaceutical industry known for its dedication to improving healthcare through innovative solutions. His work contributes to the development of effective medications that enhance patient outcomes.

Collaborations: Throughout his career, Yokoyama has collaborated with esteemed colleagues including Satoshi Sakuma and Shohei Aikawa. These teamwork efforts highlight the collective expertise and commitment to advancing pharmaceutical research and development at Shionogi & Company Limited.

Conclusion: Reiji Yokoyama's innovative work in the formulation of solid dosage forms represents a significant step forward in pharmaceutical science. His patent not only reflects his ingenuity but also has the potential to impact the way medications are developed and consumed. As he continues his work at Shionogi & Company Limited, the future of pharmaceutical innovation looks promising.